research Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia
Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.
Search
for
Sort by
Research
300-330 / 1000+ results 
research Dermatologic Implications of COVID-19 Infection and Immunization: Hair Loss
Early treatment of COVID-19-related hair loss is crucial for better outcomes.
research Hair Loss Associated with COVID-19: Problems and Solutions
COVID-19 can cause temporary hair loss due to stress and inflammation.
research Covid Induced Telogen Effluvium: An Insight
COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.
research Telogen Effluvium: A Sequela of COVID-19
COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.
research Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019
Severe hair loss is linked to worse COVID-19 outcomes, especially in younger men.
research A Hair Loss Pandemic: 19 Cases of COVID-19 Induced Telogen Effluvium
COVID-19 can cause hair loss in both severe and mild cases, often affecting women.
research Aftermath of COVID-19 Through the Eyes of Trichoscopy
COVID-19 can cause significant hair loss.
research Peculiarities of Clinical Course and Diagnosis of Alopecia Areata with Comorbidity: Clinical Observations
Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.
research Acute Versus Chronic Telogen Hair Loss: A Review of the Knowledge and Recent Facts
Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.
research Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management
Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.
research Telogen Effluvium in Patients Recovering from COVID-19
Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.
research Correlation of COVID-19 and Hairfall: A Cross-Sectional Study
COVID-19 is linked to temporary hair loss, especially in women.
research Co-Relation Between Androgenetic Alopecia and Severity of COVID-19 Disease – A Cross-Sectional Study
Androgenetic alopecia may increase the severity of COVID-19.
research Antinuclear Antibody Positivity in Patients With Hair Loss After COVID-19 Infection
Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.
research Unrecognized Underlying Condition for COVID-19: Perspective Study of Meridian and M-Shaped Male Baldness
Male pattern baldness may increase COVID-19 severity risk.
research What Does Androgenetic Alopecia Have to Do with COVID-19? An Insight into a Potential New Therapy
Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.
research Characteristics of Hair Loss in COVID-19 Patients in Thailand
COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.
research Unilateral Ciliary Madarosis in a Child After COVID-19 Infection
A child lost eyelashes on one eyelid after COVID-19, likely due to a temporary hair loss condition.
research Reply to Comment on: The Gabrin Sign
Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.
research Evaluation of the Relationship Between Favipiravir Use and Telogen Effluvium in COVID-19 Patients
Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.
research Alopecia and COVID-19: Possible Etiopathogenetic Variants and Therapeutic Approach
COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.
research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium
Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.
research Bacillary Load and Reactional States in Leprosy: A Surge in Severity During the COVID Era?
The COVID-19 pandemic has led to more severe cases of Leprosy due to delayed medical care.
research Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.
research I National Academic Congress of Dermatology
The I National Academic Congress of Dermatology in 2021 expanded to include participants from across Brazil and discussed dermatology topics, including COVID-19.
research Evaluation of Patients with Telogen Effluvium During the Pandemic: Are Monocytes Responsible for Post COVID-19 Telogen Effluvium?
Monocytes might be linked to hair loss after COVID-19.
research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium
COVID-19 infection can significantly cause temporary hair loss.
research Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19
Cepharanthine could be a strong antiviral against COVID-19.
research Dermatologic Changes in Experimental Model of Long COVID
Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.